Healthcare - Biotechnology - NASDAQ - US
$ 0.0959
-8.32 %
$ 10.4 M
Market Cap
-0.64
P/E
BALANCE SHEET
55.4 M
ASSETS
14.2 M
LIABILITIES
41.2 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Apollomics, Inc.
| Current Assets | 39.9 M |
| Cash & Short-Term Investments | 37.8 M |
| Receivables | 466 K |
| Other Current Assets | 1.64 M |
| Non-Current Assets | 15.5 M |
| Long-Term Investments | 0 |
| PP&E | 586 K |
| Other Non-Current Assets | 14.9 M |
| Current Liabilities | 13.6 M |
| Accounts Payable | 0 |
| Short-Term Debt | 4.39 M |
| Other Current Liabilities | 9.16 M |
| Non-Current Liabilities | 597 K |
| Long-Term Debt | 267 K |
| Other Non-Current Liabilities | 330 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 32.1 | 32.7 | 46.7 | 130.6 | 38.5 |
| Short Term Investments | 5.8 | 21.9 | 47.7 | 23.7 | 35.6 |
| Receivables | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 |
| Inventory | 0 | 0 | 2.3 | 0.9 | 0 |
| Other Current Assets | 1.6 | 0.6 | 2.1 | 1.9 | 0.9 |
| Total Current Assets | 39.9 | 55.8 | 99.4 | 157.7 | 75.4 |
| PP&E | 0.6 | 1.5 | 1.3 | 1.9 | 2.0 |
| Intangible Assets | 14.8 | 14.8 | 14.8 | 10.3 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 4.3 | 7.8 | 0 | 0 |
| Other Long Term Assets | 0.1 | 0.1 | 0.1 | 88 K | 1.4 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 55.4 | 76.5 | 123.4 | 169.9 | 79.1 |
| LIABILITIES | |||||
| Accounts Payable | 0 | 0 | 0 | 0 | 0 |
| Short Term Debt | 4.4 | 0.6 | 0.5 | 0.5 | 0.8 |
| Other Current Liabilities | 9.2 | 11.7 | 13.0 | 11.4 | 3.7 |
| Total Current Liabilities | 13.6 | 12.4 | 13.6 | 12.1 | 4.6 |
| Long Term Debt | 0.3 | 0.4 | 0.5 | 1.0 | 135.2 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.3 | 511.9 | 322.2 | 284.8 | 0 |
| Total Liabilities | 14.2 | 524.6 | 336.3 | 297.9 | 139.8 |
| EQUITY | |||||
| Common Stock | 9 K | 41 K | 40 K | 39 K | 36 K |
| Retained Earnings | (647.0) | (474.6) | (235.4) | (141.5) | (66.7) |
| Other Accumulative Comprehensive Income/Loss | 26.7 | 3.4 | 12.3 | 5.1 | 0.3 |
| Total Equity | 41.2 | (448.1) | (212.9) | (127.9) | (60.7) |
| Total Liabilities and Equity | 55.4 | 76.5 | 123.4 | 169.9 | 79.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 74.4 | 86.8 | 86.8 | 86.8 | 86.8 |